International Rx-to-OTC Switch Forecasts
Published October 2005
View PDF brochure
The fifth report in Kline’s Rx-to-OTC-switch
series provides forecasts of switch-candidate brands and 14
therapeutic classes in nine major markets in Europe, Asia-Pacific,
and North America from 2004 to 2009. The study offers realistic,
up-to-date forecasts based on comprehensive primary research
with industry executives in each country examined. It also provides
insights on reimbursement and payers’ perspectives on switches,
including direct input from government health ministries, third-party
payers, and managed care organizations. The study includes a
thorough review of regulatory issues in each country examined
and an in-depth analysis of the retail environment for Rx-to-OTC
switches. (Y581)
Australia
• Japan •
New Zealand
• France • Germany
• Italy •
United Kingdom
• Canada
• United States
Contact
| 
